In c4c, we are thrilled to share the recent article from the Innovative Medicines Initiative (IMI) on how to make clinical trials more kid-friendly. This article highlights the importance of involving children and young people in the design and development of clinical trials, and includes first-hand experience from Joana Claverol, a member of the c4c PPI cross-cutting…
Details“Better medicines for babies, children and young people” is the ambitious aim of c4c. To realize this goal the project must first develop a pan-European, paediatric clinical trial network, and provide a wealth of support, tools and resources to build the infrastructure to deliver more efficient and effective paediatric clinical trials. The c4c consortium has…
DetailsThe European Joint Programme for Rare Diseases has announced that 2020 will see the launch of a new funding call in pre-clinical research to develop effective therapies for rare diseases. The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project…
DetailsFollowing the successful launch of the GCP training earlier this year, c4c will shortly be launching a new online course – Involving children and young patients and families’ in designing clinical research. This course is available to principle investigators and Patient and Public Involvement (PPI) liaisons in National Hubs, to support the inclusion of children…
DetailsA key concern of the c4c consortium is that strong communication and dissemination efforts need to be put in place in order to reach the widest possible audience. We are seeking experts specialised in communications that can assist in promoting project activities and bringing knowledge on paediatric research to the wider public. As a result, we are issuing…
Details
